Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5561589 | Reproductive Toxicology | 2017 | 13 Pages |
Abstract
Due to their unpredictable interactions with many drugs and foods, MAO inhibitors such as tranylcypromine are not commonly used to treat depression and reports of use in pregnancy are rare. We report the outcome of 2 pregnancies with exposure to high doses of tranylcypromine resulting in children with a similar pattern of malformations. The aetiology is unknown but may relate to the vasoactive properties of the drug in above-therapeutic doses.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Debra Kennedy, William S. Webster, Majella Hill, Helen E. Ritchie,